Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of ENPP6 mRNA | decreases expression | 20106945
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of ENPP6 mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of ENPP6 mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ENPP6 mRNA | affects cotreatment|increases expression | 17942748
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ENPP6 mRNA | affects binding|decreases expression|increases activity | 19710929
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of ENPP6 mRNA | affects expression | 17555576
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ENPP6 mRNA | affects cotreatment|increases expression | 17942748
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
5.16 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.38 | 11752688 14514962 15322242 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.55 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.52 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
1.88 | 14692618 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
11.77 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
11.77 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.29 | 11748828 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.95 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.86 | 15885639 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
10.04 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
10.04 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.40 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.97 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
1.93 | 19084267 11161223 15668708 19289846 16202921 17261762 19155303 19103187 19142967 19288272 19189210 20390343 19189212 16273361 18855134 20859285 19011961 19410462 18351453 20005174 18629630 21152245 19115204 18821012 17049068 19200415 17893378 18425577 15565566 16873071 20544844 16818667 19221464 18984771 18815881 18997820 19487384 19066611 17440819 19244106 20065188 19059307 20135344 21138602 17242785 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.93 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
3.09 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.99 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
1.85 | 16924424 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.96 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.54 | 18850075 18670907 16120746 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
2.76 | 12371664 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.49 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
14.89 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
14.89 | 16919318 17333356 17681005 17110522 16105132 11677210 15861022 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
14.89 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.22 | 16354765 15340226 15668235 8697196 12621046 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.38 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.27 | 10048152 15322242 20055451 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.85 | 19031437 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.56 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.73 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
3.80 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.61 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
3.02 | 11462148 |
MESH:D004487 |
Edema |
|
pirinixic acid |
7.79 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
7.79 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.51 | 16714409 15322242 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
10.45 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
10.45 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
3.26 | 17893378 19155303 20544844 16202921 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.37 | 10568697 9294722 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.27 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
22.04 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
22.04 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
22.04 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
22.04 | 19224547 14986274 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.43 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.94 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
5.07 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.72 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
10.14 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
10.14 | 20067830 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.76 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
5.21 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.49 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.73 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.96 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.71 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
9.92 | 16221962 19176532 18467677 19772884 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
9.92 | 15340226 16120746 12621046 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.66 | 8697196 16354765 15340226 16959395 18606429 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.53 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.31 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.31 | 18670907 18850075 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
4.29 | 16569931 16945680 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.87 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.71 | 17937319 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
5.43 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.43 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.85 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.71 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
5.05 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.52 | 8314463 10903974 18776723 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
8.33 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
8.33 | 18625569 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.40 | 17567588 15342952 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.56 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
3.56 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.56 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
7.99 | 15890375 20007298 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
7.99 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.99 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.31 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
2.33 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.33 | 11884234 19555203 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
4.30 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
2.83 | 14580682 19196722 11731420 16827153 19196723 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
5.16 | 19453300 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
1.92 | 19393235 12393984 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.72 | 15990972 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.40 | 16801185 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.99 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.26 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.31 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.22 | 16411023 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.66 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.60 | 19410462 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
2.09 | 17405874 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.61 | 19189210 19196722 19200415 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
5.05 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.61 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.65 | 14600291 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.88 | 20558911 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
4.09 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.86 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
4.00 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.55 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.73 | 11896295 11118676 11399792 11222880 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
3.09 | 15067354 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.85 | 15861022 16919318 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.32 | 16882103 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.53 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.28 | 18990726 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.18 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
13.69 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
13.69 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
4.58 | 19457130 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
4.02 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.48 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.51 | 12697716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
2.46 | 16712894 17572228 8653321 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.74 | 14692618 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.59 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
5.21 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.91 | 14671159 15869587 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.86 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
5.05 | 17120751 |